by GlobeNewsWire | Jun 23, 2018 | Globe Newswire
Sotagliflozin, in Combination with Insulin, Significantly Decreased A1C Levels and Reduced Weight at 52 Weeks Results Observed at 24 Weeks Persisted at 52 Weeks THE WOODLANDS, Texas, June 23, 2018 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX),...
by GlobeNewsWire | Jun 23, 2018 | Globe Newswire
Trial met all primary objectives, demonstrated efficacy and safety and established minimally effective dose of 0.9 mg for ZGN-1061 Patient dosing recently initiated for the 1.8 mg dose cohort Zafgen presenting the Phase 2 clinical data and data from two supportive...
by GlobeNewsWire | Jun 23, 2018 | Globe Newswire
KEMP, Texas, June 23, 2018 (GLOBE NEWSWIRE) — Industrial lighting leader, Larson Electronics LLC, has released an explosion proof signal stack LED light with two colored LED lenses, designed for use as illuminative signaling in hazardous environments. This...
by GlobeNewsWire | Jun 23, 2018 | Globe Newswire
Poster 1017-P: Afrezza provides improved Time-in-Range on Continuous Glucose Monitoring compared to insulin aspart Poster 102-LB: Hypoglycemia is reduced with use of Afrezza compared to insulin aspart WESTLAKE VILLAGE, Calif., June 23, 2018 (GLOBE NEWSWIRE) —...
by GlobeNewsWire | Jun 23, 2018 | Globe Newswire
Company surpasses $1M in accepted investments; expects to make significant scientific announcement in the near futureCHICAGO, June 23, 2018 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable...